Expansion from tx.hl7chile.cl based on codesystem International Classification of Diseases, 11th Revision Mortality and Morbidity Statistics (MMS) version 2026-01
This value set has 1,700 codes in it. In order to keep the publication size manageable, only a selection (1,000 codes) of the whole set of codes is shown.
System Code Display (en) JSON XML http://id.who.int/icd/release/11/mms XH96Q1 Adenoma de células acinares http://id.who.int/icd/release/11/mms XH3PG9 Carcinoma de células acinosas http://id.who.int/icd/release/11/mms XH99S4 Cistadenocarcinoma de células acinosas http://id.who.int/icd/release/11/mms XH9B93 Carcinoma acinar- ductal mixto http://id.who.int/icd/release/11/mms XH0F68 Adenocarcinoma acinar de pulmón http://id.who.int/icd/release/11/mms XH2SK9 Tumor de células acinosas http://id.who.int/icd/release/11/mms XH9574 Adenoma acidófilo http://id.who.int/icd/release/11/mms XH3DV3 Adenoma, SAI http://id.who.int/icd/release/11/mms XH1CV4 Poliposis adenomatosa coli http://id.who.int/icd/release/11/mms XH1YP0 Adenoma cortical suprarrenal, de células claras http://id.who.int/icd/release/11/mms XH2CT2 Adenoma cortical suprarrenal, de células compactas http://id.who.int/icd/release/11/mms XH60N5 Adenoma cortical suprarrenal, de células glomerulosas http://id.who.int/icd/release/11/mms XH2VZ8 Adenoma cortical suprarrenal, de células mixtas http://id.who.int/icd/release/11/mms XH2FJ6 Adenoma cortical suprarrenal, pigmentado http://id.who.int/icd/release/11/mms XH9356 Adenoma alveolar http://id.who.int/icd/release/11/mms XH60D1 Adenoma de células basales http://id.who.int/icd/release/11/mms XH3AH8 Adenoma basófilo http://id.who.int/icd/release/11/mms XH6KR6 Adenoma del conducto biliar http://id.who.int/icd/release/11/mms XH0778 Citoadenoma del conducto biliar http://id.who.int/icd/release/11/mms XH7BS0 Neoplasia intraepitelial biliar, de bajo grado http://id.who.int/icd/release/11/mms XH5YG5 Papilomatosis biliar http://id.who.int/icd/release/11/mms XH1TD7 Adenoma canalicular http://id.who.int/icd/release/11/mms XH6WK1 Adenoma de células pincipales http://id.who.int/icd/release/11/mms XH7475 Adenoma cromófobo http://id.who.int/icd/release/11/mms XH9JJ4 Adenofibroma de células claras http://id.who.int/icd/release/11/mms XH8R87 Adenoma de células claras http://id.who.int/icd/release/11/mms XH6J91 Cilindroma de la piel http://id.who.int/icd/release/11/mms XH5GN1 Cilindroma dérmico ecrino http://id.who.int/icd/release/11/mms XH6685 Adenoma embrionario http://id.who.int/icd/release/11/mms XH3K13 Displasia esofágica glandular (neoplasia intraepitelial) de bajo grado http://id.who.int/icd/release/11/mms XH83X4 Adenoma plana http://id.who.int/icd/release/11/mms XH0LM0 Adenoma folicular http://id.who.int/icd/release/11/mms XH5SM2 Adenoma folicular, de células oxifílicas http://id.who.int/icd/release/11/mms XH6AF9 Neoplasia intraepitelial glandular de grado bajo http://id.who.int/icd/release/11/mms XH3BK2 Papiloma glandular http://id.who.int/icd/release/11/mms XH6PG8 Adenoma de células de Hurthle http://id.who.int/icd/release/11/mms XH5X53 Tumor de células de Hürthle http://id.who.int/icd/release/11/mms XH6M13 Tumor yuxtaglomerular http://id.who.int/icd/release/11/mms XH0W31 Adenoma de la lactancia http://id.who.int/icd/release/11/mms XH8P28 Lipoadenoma http://id.who.int/icd/release/11/mms XH68V1 Adenoma de células hepáticas http://id.who.int/icd/release/11/mms XH19E3 Adenoma macrofolicular http://id.who.int/icd/release/11/mms XH0JC7 Adenoma metanefrico http://id.who.int/icd/release/11/mms XH3DH3 Adenoma microquístico http://id.who.int/icd/release/11/mms XH5LD9 Adenoma acidófilo-basófilo mixto http://id.who.int/icd/release/11/mms XH0WV8 Pólipo hiperplásico y adenomatoso mixto http://id.who.int/icd/release/11/mms XH1XU4 Adenoma de células mixtas http://id.who.int/icd/release/11/mms XH2CQ8 Adenoma monomórfico http://id.who.int/icd/release/11/mms XH6CZ4 Pólipos adenomatosos múltiples http://id.who.int/icd/release/11/mms XH9Z86 Adenoma oxifílico http://id.who.int/icd/release/11/mms XH0BF2 Neoplasia pancreatobiliar, no invasiva http://id.who.int/icd/release/11/mms XH6GG6 Microadenoma pancreatico http://id.who.int/icd/release/11/mms XH1BH4 Papilomatosis, glandular http://id.who.int/icd/release/11/mms XH6EJ4 Adenoma papilotubular http://id.who.int/icd/release/11/mms XH1QS0 Adenoma lactotrofo http://id.who.int/icd/release/11/mms XH5903 Adenoma serrado http://id.who.int/icd/release/11/mms XH9G87 Adenoma trabecular http://id.who.int/icd/release/11/mms XH8T50 Tumor de Turban http://id.who.int/icd/release/11/mms XH0731 Papiloma velloso http://id.who.int/icd/release/11/mms XH8UC1 Adenoma de células en aguas claras http://id.who.int/icd/release/11/mms XH28X1 Cilindroma de mama http://id.who.int/icd/release/11/mms XH8MU5 Pólipo adenomatoso,SAI http://id.who.int/icd/release/11/mms XH7SY6 Adenoma tubular, SAI http://id.who.int/icd/release/11/mms XH2F06 Adenoma serrado sésil http://id.who.int/icd/release/11/mms XH63V9 Pólipo serrado sésil http://id.who.int/icd/release/11/mms XH9PD9 Adenoma serrado sésil tradicional http://id.who.int/icd/release/11/mms XH5QL3 Hiperplasia adenomatosa atípica http://id.who.int/icd/release/11/mms XH09B0 Adenoma papilar, SAI http://id.who.int/icd/release/11/mms XH90D6 Adenoma velloso, SAI http://id.who.int/icd/release/11/mms XH10B0 Adenoma tubulovelloso, SAI http://id.who.int/icd/release/11/mms XH94U0 Adenoma pituitario, SAI http://id.who.int/icd/release/11/mms XH26P7 Oncocitoma de células fusiformes http://id.who.int/icd/release/11/mms XH52F6 Adenoma cortical adrenal, SAI http://id.who.int/icd/release/11/mms XH6ZD0 Adenoma endometroide, SAI http://id.who.int/icd/release/11/mms XH1CX5 Adenofibroma endometroide, SAI http://id.who.int/icd/release/11/mms XH2H83 Adenoma microfolicular, SAI http://id.who.int/icd/release/11/mms XH7DU3 Adenoma tipo intestinal http://id.who.int/icd/release/11/mms XH1Q16 Microadenoma neuroendocrino pancreático http://id.who.int/icd/release/11/mms XH8NK5 Cistadenoma papilar oncocítico http://id.who.int/icd/release/11/mms XH8Y40 Adenoma de células nulas http://id.who.int/icd/release/11/mms XH1JL3 Adenoma plurihormonal http://id.who.int/icd/release/11/mms XH50K4 Adenoma gonadotropo http://id.who.int/icd/release/11/mms XH4HE3 Adenoma somatótrofo http://id.who.int/icd/release/11/mms XH0MY4 Adenoma tirótrofo http://id.who.int/icd/release/11/mms XH5RH2 Adenoma hipofisario ectópico http://id.who.int/icd/release/11/mms XH1C58 Adenoma corticotropo http://id.who.int/icd/release/11/mms XH7743 Adenoma bronquiolar / Tumor papilar muconodular ciliado http://id.who.int/icd/release/11/mms XH2L30 Adenocarcinoma in situ, SAI http://id.who.int/icd/release/11/mms XH4J07 Adenocarcinoma in situ en pólipo adenomatoso http://id.who.int/icd/release/11/mms XH3770 Adenocarcinoma in situ en adenoma tubovelloso http://id.who.int/icd/release/11/mms XH8TV2 Adenocarcinoma in situ en adenoma velloso http://id.who.int/icd/release/11/mms XH5U91 Neoplasia intraepiteliai biliar, de alto grado http://id.who.int/icd/release/11/mms XH7Y32 Carcinoma cribiforme in situ http://id.who.int/icd/release/11/mms XH0557 Carcinoma ductal in situ, tipo sólido http://id.who.int/icd/release/11/mms XH36M5 Displasia glandular esofágica (neoplasia intraepitelial) de alto grado http://id.who.int/icd/release/11/mms XH5161 Neoplasia glandular intraepitelial plano, de alto grado http://id.who.int/icd/release/11/mms XH28N7 Neoplasia intraepitelial glandular, de alto grado http://id.who.int/icd/release/11/mms XH26M2 Neoplasia papilar, tipo pancreatobiliar, conneoplasia intraepitelial de alto grado http://id.who.int/icd/release/11/mms XH5C49 Neoplasia intraepitelial prostática, grado III http://id.who.int/icd/release/11/mms XH1FR9 Adenocarcinoma in situ de pulmón, no mucinoso http://id.who.int/icd/release/11/mms XH6BU6 Adenocarcinoma in situ de pulmón mucinoso http://id.who.int/icd/release/11/mms XH4Z68 Neoplasia intraepitelial endometroide http://id.who.int/icd/release/11/mms XH2QZ6 Carcinoma acidófilo http://id.who.int/icd/release/11/mms XH5LA4 Tumor adenocarcinoide http://id.who.int/icd/release/11/mms XH74S1 Adenocarcinoma, SAI http://id.who.int/icd/release/11/mms XH7QZ0 Adenocarcinoma en pólipo adenomatoso http://id.who.int/icd/release/11/mms XH2ZH8 Adenocarcinoma en poliposis adenomatosa coli http://id.who.int/icd/release/11/mms XH9YR3 Adenocarcinoma en múltiples pólipos adenomatosos http://id.who.int/icd/release/11/mms XH7QB1 Adenocarcinoma en adenoma túbulovelloso http://id.who.int/icd/release/11/mms XH6DA5 Adenocarcinoma en adenoma velloso http://id.who.int/icd/release/11/mms XH5RE1 Adenocarcinoma de las glándulas anales http://id.who.int/icd/release/11/mms XH2ZQ0 Adenocarcinoma con subtipos mixtos http://id.who.int/icd/release/11/mms XH0349 Adenocarcinoma, tipo intestinal http://id.who.int/icd/release/11/mms XH8B45 Carcinoma sólido, SAI http://id.who.int/icd/release/11/mms XH8DS0 Tumor neuroendocrino, SAI http://id.who.int/icd/release/11/mms XH8LX8 Carcinoma neuroendocrino, de bajo grado http://id.who.int/icd/release/11/mms XH55D7 Carcinoma neuroendócrino, bien diferenciado http://id.who.int/icd/release/11/mms XH9LV8 Tumor neuroendocrino, grado 1 http://id.who.int/icd/release/11/mms XH7NM1 Carcinoides de células enterocromafines http://id.who.int/icd/release/11/mms XH0U20 Carcinoma neuroendócrino, SAI http://id.who.int/icd/release/11/mms XH7F73 Carcinoma neuroendócrino, moderadamente diferenciado http://id.who.int/icd/release/11/mms XH24W2 Adenocarcinoma lepídico http://id.who.int/icd/release/11/mms XH3QM0 Adenocarcinoma mínimamente invasivo, No mucinoso http://id.who.int/icd/release/11/mms XH4302 Carcinoma quístico adenoide http://id.who.int/icd/release/11/mms XH2098 Adenocarcinoma mínimamente invasivo, Mucinoso http://id.who.int/icd/release/11/mms XH6LV9 Adenocarcinoma papilar, SAI http://id.who.int/icd/release/11/mms XH95U1 Carcinoma villoglandular http://id.who.int/icd/release/11/mms XH6QG3 Carcinoma micropapilar, SAI http://id.who.int/icd/release/11/mms XH4MW7 Adenocarcinoma micropapilar http://id.who.int/icd/release/11/mms XH7KL6 Carcinoma hipofisatio, SAI http://id.who.int/icd/release/11/mms XH6L02 Adenocarcinoma de células claras, SAI http://id.who.int/icd/release/11/mms XH5085 Leiomiomatosis hereditaria y carcinoma de células renales (LHCCR) síndrome asociado con carcinoma de células renales http://id.who.int/icd/release/11/mms XH1442 Carcinomas de traslocación familiar MiT http://id.who.int/icd/release/11/mms XH8EN1 Carcinoma de células renales deficiente en succinato deshidrogenasa http://id.who.int/icd/release/11/mms XH07X3 Adenocarcinoma alveolar http://id.who.int/icd/release/11/mms XH05V6 Carcinoma de células renales, SAI http://id.who.int/icd/release/11/mms XH3Z08 Carcinoma de células renales, sin clasificar http://id.who.int/icd/release/11/mms XH0RU3 Carcinoma de células renales asociada a enfermedad quística adquirida http://id.who.int/icd/release/11/mms XH7K79 Carcinoma de células renales tubuloquística http://id.who.int/icd/release/11/mms XH1VB1 Tumor cromófobo oncocítico híbrido http://id.who.int/icd/release/11/mms XH3Z50 Carcinoma folicular, SAI http://id.who.int/icd/release/11/mms XH9508 Adenocarcinoma endometrioide, variante de células ciliadas http://id.who.int/icd/release/11/mms XH0718 Adenocarcinoma endometrioide, variante secretoria http://id.who.int/icd/release/11/mms XH4KH2 Carcinoma cortical adrenal http://id.who.int/icd/release/11/mms XH0SD2 Adenocarcinoma endometrioide, SAI http://id.who.int/icd/release/11/mms XH51K1 Tumor neuroendocrino, grado 2 http://id.who.int/icd/release/11/mms XH09B7 Cistoadenocarcinoma endometrioide http://id.who.int/icd/release/11/mms XH6KR7 Adenofibroma endometrioide, maligno http://id.who.int/icd/release/11/mms XH0GS9 Adenocarcinoma, tipo endocervical http://id.who.int/icd/release/11/mms XH8SF8 Adenomatosis de células de los islotes http://id.who.int/icd/release/11/mms XH43E4 Colangiocarcinoma perihiliar http://id.who.int/icd/release/11/mms XH4BY1 Adenoma de células del islote http://id.who.int/icd/release/11/mms XH3CU4 Variante villoglandular del adenocarcinoma endometrioide http://id.who.int/icd/release/11/mms XH5QV8 Blastoma pituitario http://id.who.int/icd/release/11/mms XH0Y80 Carcinoma folicular, encapsulado, angioinvasivo http://id.who.int/icd/release/11/mms XH46F1 Carcinoma renal de células claras, SAI http://id.who.int/icd/release/11/mms XH9SA7 Adenocarcinoma de células basales http://id.who.int/icd/release/11/mms XH85C2 Tumor del saco endolinfático http://id.who.int/icd/release/11/mms XH4PB1 Adenocarcinoma acinar de próstata http://id.who.int/icd/release/11/mms XH8E54 Neoplasia mixta neuroendocrina no neuroendocrina (MMiNEN) http://id.who.int/icd/release/11/mms XH5QW8 Tumor neuroendocrino, grado 3 http://id.who.int/icd/release/11/mms XH1NL5 Nesidioblastoma http://id.who.int/icd/release/11/mms XH5XB7 Carcinoma de células de los islotes http://id.who.int/icd/release/11/mms XH2ST7 Tumor de células de los islotes, SAI http://id.who.int/icd/release/11/mms XH4SH8 Insulinoma, SAI http://id.who.int/icd/release/11/mms XH93H8 Gastrinoma http://id.who.int/icd/release/11/mms XH7JQ0 Carcinoma de paratiroides http://id.who.int/icd/release/11/mms XH9LV7 Carcinoma basófilo http://id.who.int/icd/release/11/mms XH7152 Tumor productor de péptido similar al glucagón http://id.who.int/icd/release/11/mms XH7LW9 Tumor de células -L http://id.who.int/icd/release/11/mms XH9ZS8 Péptido pancreático y péptido similar al péptido pancreático dentro del tumor productor de tirosina amida terminal http://id.who.int/icd/release/11/mms XH4NQ8 Glucagonoma http://id.who.int/icd/release/11/mms XH2PF0 Enteroglucagonoma http://id.who.int/icd/release/11/mms XH72E5 Vipoma http://id.who.int/icd/release/11/mms XH5VH0 Somatostatinoma http://id.who.int/icd/release/11/mms XH41P2 Tumor endocrino funcionante, SAI http://id.who.int/icd/release/11/mms XH7AG8 Tumor productor de ACTH [hormona adrenocorticotrópica] http://id.who.int/icd/release/11/mms XH60V1 Carcinoma medular de tiroides http://id.who.int/icd/release/11/mms XH3BU6 Cistoadenocarcinoma del conducto biliar http://id.who.int/icd/release/11/mms XH2MW1 Carcinoma medular con estroma amiloide http://id.who.int/icd/release/11/mms XH8VU6 Carcinoma de tiroides pobremente diferenciado http://id.who.int/icd/release/11/mms XH4NH4 Tumor neuroendocrino hipofisario http://id.who.int/icd/release/11/mms XH2ZA2 Adenoma bronquial, carcinoide http://id.who.int/icd/release/11/mms XH5TR7 Carcinoma de pulmón, mixto mucinoso y no- mucinoso http://id.who.int/icd/release/11/mms XH7GY6 Adenocarcinoma de pulmón, mucinoso http://id.who.int/icd/release/11/mms XH2035 Carcinoma bronquiolo-alveolar, no mucinoso http://id.who.int/icd/release/11/mms XH6LF9 Carcinoma simple http://id.who.int/icd/release/11/mms XH0XL5 Carcinoma, de tipo difuso http://id.who.int/icd/release/11/mms XH7M15 Colangiocarcinoma http://id.who.int/icd/release/11/mms XH7SS7 Carcinoma cromófobo http://id.who.int/icd/release/11/mms XH2Q13 Adenocarcinofibroma de células claras http://id.who.int/icd/release/11/mms XH6YS0 Adenocarcinoma de células claras, mesonefroide http://id.who.int/icd/release/11/mms XH4SQ4 Carcinoma del ducto colector http://id.who.int/icd/release/11/mms XH7QJ6 Carcinoma hepatocelular y colangiocarcinoma combinado http://id.who.int/icd/release/11/mms XH4KK0 Quistes asociados con carcinoma de células renales http://id.who.int/icd/release/11/mms XH0LH8 Tumor de células similares a enterocromafines http://id.who.int/icd/release/11/mms XH5P16 Adenocarcinoma fetal http://id.who.int/icd/release/11/mms XH7TE3 Adenocarcinoma folicular, moderadamente diferenciado http://id.who.int/icd/release/11/mms XH0VD1 Adenocarcinoma folicular, trabecular http://id.who.int/icd/release/11/mms XH8FK7 Adenocarcinoma folicular, bien diferenciado http://id.who.int/icd/release/11/mms XH3DN7 Carcinoma folicular, mínimamente invasivo http://id.who.int/icd/release/11/mms XH90N9 Carcinoma folicular, de células oxifílicas http://id.who.int/icd/release/11/mms XH3XT5 Carcinoma rico en glicógeno http://id.who.int/icd/release/11/mms XH4262 Tumor carcinoide de células caliciformes http://id.who.int/icd/release/11/mms XH2EH4 Carcinoma de células granulares http://id.who.int/icd/release/11/mms XH4T58 Carcinoma hepatocelular, tipo células claras http://id.who.int/icd/release/11/mms XH9Q35 Carcinoma hepatocelular, fibrolamelar http://id.who.int/icd/release/11/mms XH0G90 Hepatocellular carcinoma, tipo pleomórfico http://id.who.int/icd/release/11/mms XH5761 Carcinoma hepatocelular, escirroso http://id.who.int/icd/release/11/mms XH3T17 Carcinoma hepatocelular, variante de células fusiformes http://id.who.int/icd/release/11/mms XH6YH5 Adenocarcinoma de células de Hürthle http://id.who.int/icd/release/11/mms XH8MQ3 Carcinoma de células Hürthle http://id.who.int/icd/release/11/mms XH8WM4 Linitis plástica http://id.who.int/icd/release/11/mms XH6TK0 Carcinoma rico en lípidos http://id.who.int/icd/release/11/mms XH81N8 Carcinoma de las células de Merkel http://id.who.int/icd/release/11/mms XH7019 Carcinoma acidófilo-basófilo mixto http://id.who.int/icd/release/11/mms XH8EZ3 Carcinoma mixto acinar-endocrino http://id.who.int/icd/release/11/mms XH74Y9 Carcinoma acinar-endocrino-ductal mixto http://id.who.int/icd/release/11/mms XH6H10 Carcinoma adenoneuroendocrino mixto http://id.who.int/icd/release/11/mms XH2AM6 Adenocarcinoma de células mixtas http://id.who.int/icd/release/11/mms XH7CY5 Carcinoma mixto ductal-endocrino http://id.who.int/icd/release/11/mms XH6UP4 Adenocarcinoma exocrino y endocrino mixto http://id.who.int/icd/release/11/mms XH7DG7 Carcinoma medular-folicular mixto http://id.who.int/icd/release/11/mms XH3340 Carcinoma medular-papilar mixto http://id.who.int/icd/release/11/mms XH9LZ7 Tumor mixto exocrino y endocrino pancreático , maligno http://id.who.int/icd/release/11/mms XH1108 Carcinoma esclerosante no encapsulado http://id.who.int/icd/release/11/mms XH09D6 Adenocarcinoma oxifílico http://id.who.int/icd/release/11/mms XH3614 Adenocarcinoma de células de los islotes (Langerhans) http://id.who.int/icd/release/11/mms XH3709 Tumor neuroendocrino pancreático, no funcional http://id.who.int/icd/release/11/mms XH6XY9 Carcinoma tipo- pancreatobiliar http://id.who.int/icd/release/11/mms XH1ND9 Carcinoma papilar de tiroides http://id.who.int/icd/release/11/mms XH85E5 Carcinoma papilar, de células columnares http://id.who.int/icd/release/11/mms XH0426 Carcinoma papilar, esclerosante difuso http://id.who.int/icd/release/11/mms XH0Q59 Carcinoma papilar, encapsulado de tiroides http://id.who.int/icd/release/11/mms XH29M4 Carcinoma papilar, variante folicular http://id.who.int/icd/release/11/mms XH5YT2 Carcinoma papilar, variante oncocítico http://id.who.int/icd/release/11/mms XH2AW7 Microcarcinoma papilar http://id.who.int/icd/release/11/mms XH1D07 Carcinoma de células renales papilares http://id.who.int/icd/release/11/mms XH4Q20 Adenocarcinoma papilar tubular http://id.who.int/icd/release/11/mms XH1JZ0 Carcinoma de células parietales http://id.who.int/icd/release/11/mms XH6153 Carcinoma de células renales, de tipo cromófobo http://id.who.int/icd/release/11/mms XH9DH7 Carcinoma de células renales, sarcomatoides http://id.who.int/icd/release/11/mms XH4FS4 Adenocarcinoma escirroso http://id.who.int/icd/release/11/mms XH34G3 Carcinoma sólido con formación de mucina http://id.who.int/icd/release/11/mms XH0JE3 Adenocarcinoma de extensión superficial http://id.who.int/icd/release/11/mms XH7EX3 Adenocarcinoma trabecular http://id.who.int/icd/release/11/mms XH4TA4 Adenocarcinoma tubular http://id.who.int/icd/release/11/mms XH1Z69 Carcinoide típico http://id.who.int/icd/release/11/mms XH22Z8 Carcinoma de glándulas de Skene, de Cowper y de Littre http://id.who.int/icd/release/11/mms XH0X20 Adenocarcinoma velloso http://id.who.int/icd/release/11/mms XH0A57 Adenocarcinoma de células claras del agua http://id.who.int/icd/release/11/mms XH8UE4 Adenocarcinoma, metastático, SAI http://id.who.int/icd/release/11/mms XH4ZC3 Carcinoma de células basales de la próstata http://id.who.int/icd/release/11/mms XH4W48 Carcinoma hepatocelular, SAI http://id.who.int/icd/release/11/mms XH81Q9 Adenoma bronquial, cilindroide http://id.who.int/icd/release/11/mms XH92Y9 Carcinoma tímico con características de carcinoma adenoide quístico http://id.who.int/icd/release/11/mms XH1YZ3 Carcinoma cribiforme, SAI http://id.who.int/icd/release/11/mms XH4YG1 Carcinoma tipo comedo-cribiforme http://id.who.int/icd/release/11/mms XH74B2 Adenocarcinoma serrado http://id.who.int/icd/release/11/mms XH6770 Apudoma http://id.who.int/icd/release/11/mms XH6VL9 Adenoma atípico http://id.who.int/icd/release/11/mms XH3T38 Adenoma folicular atípico http://id.who.int/icd/release/11/mms XH0S86 Adenofibroma de células claras de malignidad borderline http://id.who.int/icd/release/11/mms XH5DQ2 Adenoma endometroide, de malignidad borderline http://id.who.int/icd/release/11/mms XH76W6 Adenomas endocrinos múltiples http://id.who.int/icd/release/11/mms XH8468 Adenomatosis pulmonar http://id.who.int/icd/release/11/mms XH54H3 Tumor hipernefroide http://id.who.int/icd/release/11/mms XH7PR9 Neoplasia renal quística multilocular de bajo potencial de malignidad http://id.who.int/icd/release/11/mms XH9DS4 Adenofibroma endometrioide, de malignidad borderline http://id.who.int/icd/release/11/mms XH4JG0 Tumor carcinoide tubular http://id.who.int/icd/release/11/mms XH4XL2 Tumor papilar agresivo http://id.who.int/icd/release/11/mms XH9PN4 Tumor bien diferenciado de potencial maligno incierto http://id.who.int/icd/release/11/mms XH6SY0 Neoplasia folicular de tiroides no invasiva con características nucleares de tipo papilar (NFTNITP) http://id.who.int/icd/release/11/mms XH1Y66 Tumor trabecular hialinizante http://id.who.int/icd/release/11/mms XH27W5 Tumor folicular de potencial maligno incierto http://id.who.int/icd/release/11/mms XH9T60 Carcinoma renal de células papilares claras http://id.who.int/icd/release/11/mms XH6CZ3 Tumor borderline de células claras http://id.who.int/icd/release/11/mms XH6YZ9 Adenoma apócrino http://id.who.int/icd/release/11/mms XH0AQ8 Hidradenoma de células claras http://id.who.int/icd/release/11/mms XH46Z2 Acrospiroma ecrino http://id.who.int/icd/release/11/mms XH42Z3 Adenoma papilar écrino http://id.who.int/icd/release/11/mms XH25Z9 Poroma ecrino http://id.who.int/icd/release/11/mms XH3AM1 Espiradenoma, SAI http://id.who.int/icd/release/11/mms XH4YU8 Fibroma folicular http://id.who.int/icd/release/11/mms XH7NR3 Hidrocistoma http://id.who.int/icd/release/11/mms XH4MV7 Hidradenoma, SAI http://id.who.int/icd/release/11/mms XH4DX4 Hidradenoma papilar http://id.who.int/icd/release/11/mms XH1PY0 Siringoadenoma papilifero http://id.who.int/icd/release/11/mms XH96Q5 Adenoma apendicular de la piel http://id.who.int/icd/release/11/mms XH3U61 Adenoma de glándula sudorípara http://id.who.int/icd/release/11/mms XH06Y5 Siringofibroadenoma http://id.who.int/icd/release/11/mms XH6325 Siringoma, SAI http://id.who.int/icd/release/11/mms XH9GB7 Tumor siringomatoso del pezón http://id.who.int/icd/release/11/mms XH1NC5 Adenoma sebáceo http://id.who.int/icd/release/11/mms XH0SH5 Epitelioma sebáceo http://id.who.int/icd/release/11/mms XH7AL8 Adenoma ceruminoso http://id.who.int/icd/release/11/mms XH8R55 Tricodiscoma de predominio de células fusiformes http://id.who.int/icd/release/11/mms XH1A80 Poroma apocrino http://id.who.int/icd/release/11/mms XH8N28 Poroma, SAI http://id.who.int/icd/release/11/mms XH0QL4 Sebaceoma http://id.who.int/icd/release/11/mms XH7WE6 Porocarcinoma in situ http://id.who.int/icd/release/11/mms XH9L77 Adenocarcinoma apócrino http://id.who.int/icd/release/11/mms XH6FB5 Adenocarcinoma papilar digital http://id.who.int/icd/release/11/mms XH7VK4 Porocarcinoma SAI http://id.who.int/icd/release/11/mms XH58E1 Espiradenoma ecrino maligno http://id.who.int/icd/release/11/mms XH7NK9 Hidradenocarcinoma http://id.who.int/icd/release/11/mms XH17P2 Carcinoma microquístico anexal http://id.who.int/icd/release/11/mms XH89V4 Adenocarcinoma anexial, SAI http://id.who.int/icd/release/11/mms XH5LY3 Adenocarcinoma de glándula sudorípara http://id.who.int/icd/release/11/mms XH4VR2 Carcinoma sebáceo http://id.who.int/icd/release/11/mms XH8NE4 Adenocarcinoma ecrino http://id.who.int/icd/release/11/mms XH6Z69 Adenocarcinoma ceruminoso http://id.who.int/icd/release/11/mms XH9C82 Neoplasia maligna que surge de un espiradenoma preexistente http://id.who.int/icd/release/11/mms XH2ZK9 Neoplasia maligna que surge de un cilindroma preexistente http://id.who.int/icd/release/11/mms XH9NW9 Neoplasia maligna que surge de un espiradenocilindroma preexistente http://id.who.int/icd/release/11/mms XH65F9 Sialadenoma papilífero http://id.who.int/icd/release/11/mms XH0BE5 Siringocistadenocarcinoma papilífero http://id.who.int/icd/release/11/mms XH8BW1 Tumor de glándula sudorípara, SAI http://id.who.int/icd/release/11/mms XH1PG0 Epitelioma intraepidérmico de Jadassohn http://id.who.int/icd/release/11/mms XH5AU2 Triquilemoma http://id.who.int/icd/release/11/mms XH6QT9 Tricoepitelioma http://id.who.int/icd/release/11/mms XH0U05 Tricofoliculoma http://id.who.int/icd/release/11/mms XH5L76 Tumor pilar http://id.who.int/icd/release/11/mms XH9E37 Pilomatricoma, SAI http://id.who.int/icd/release/11/mms XH05Z3 Tricogerminoma http://id.who.int/icd/release/11/mms XH7CM2 Matricoma melanocítico http://id.who.int/icd/release/11/mms XH3EY8 Acantoma de la vaina pilosa http://id.who.int/icd/release/11/mms XH0489 Tumor de infundíbulo folicular http://id.who.int/icd/release/11/mms XH2K97 Tricoblastoma http://id.who.int/icd/release/11/mms XH70J2 Carcinoma basal adenoide http://id.who.int/icd/release/11/mms XH45F3 Carcinoma de células basales, fibroepitelial http://id.who.int/icd/release/11/mms XH4GJ2 Carcinoma de células basales, miconodular http://id.who.int/icd/release/11/mms XH2CR0 Carcinoma basocelular, nodular http://id.who.int/icd/release/11/mms XH2615 Carcinoma de células basales, SAI http://id.who.int/icd/release/11/mms XH4C18 Carcinoma basoescamoso http://id.who.int/icd/release/11/mms XH5VK4 Carcinoma basocelular infiltrante, SAI http://id.who.int/icd/release/11/mms XH0T12 Carcinoma basocelular infiltrante, no esclerosante http://id.who.int/icd/release/11/mms XH67Y4 Carcinoma basocelular infiltrante, esclerosante http://id.who.int/icd/release/11/mms XH9E93 Carcinoma metatípico http://id.who.int/icd/release/11/mms XH5NL6 Carcinoma basocelular superficial http://id.who.int/icd/release/11/mms XH2HE7 Carcinoma basocelular pigmentado http://id.who.int/icd/release/11/mms XH9K96 Triquilemocarcinoma http://id.who.int/icd/release/11/mms XH9G49 Carcinoma pilomatrical http://id.who.int/icd/release/11/mms XH6S67 Carcinoma basocelular con diferenciación anexial http://id.who.int/icd/release/11/mms XH3DL9 Carcinoma tricoblástico http://id.who.int/icd/release/11/mms XH8324 Carcinosarcoma tricoblástico http://id.who.int/icd/release/11/mms XH1JH6 Carcinoma de células basales, sarcomatoide http://id.who.int/icd/release/11/mms XH8189 Tumor de células basales http://id.who.int/icd/release/11/mms XH7WJ7 Quiste triquilemal proliferante http://id.who.int/icd/release/11/mms XH3U29 Hemangioma capilar http://id.who.int/icd/release/11/mms XH1GU2 Hemangioma cavernoso http://id.who.int/icd/release/11/mms XH10T4 Hemangioma epitelioide http://id.who.int/icd/release/11/mms XH0LN3 Hemangioendotelioma, benigno http://id.who.int/icd/release/11/mms XH0553 Hemangioma intramuscular http://id.who.int/icd/release/11/mms XH2HR3 Hemangioma racimoso http://id.who.int/icd/release/11/mms XH4NS3 Hemangioma venoso http://id.who.int/icd/release/11/mms XH5AW4 Hemangioma, SAI http://id.who.int/icd/release/11/mms XH37N4 Miointimoma http://id.who.int/icd/release/11/mms XH1JJ2 Angiofibroma, SAI http://id.who.int/icd/release/11/mms XH23S6 Hemangioma queratósico verrugoso http://id.who.int/icd/release/11/mms XH4E06 Angiofibroma celular http://id.who.int/icd/release/11/mms XH73S9 Angiofibroma de células gigantes http://id.who.int/icd/release/11/mms XH2EX4 Hemangioma en penacho adquirido http://id.who.int/icd/release/11/mms XH4KP7 Angioqueratoma http://id.who.int/icd/release/11/mms XH8SM9 Nódulo angiomatoide epitelioide cutáneo http://id.who.int/icd/release/11/mms XH8KN7 Lesión vascular atípica http://id.who.int/icd/release/11/mms XH9Q71 Hemangioma cereza http://id.who.int/icd/release/11/mms XH88L5 Hemangioma sinusoidal http://id.who.int/icd/release/11/mms XH9UU3 Hemangioma microvenular http://id.who.int/icd/release/11/mms XH9NB0 Hemangioma glomeruloide http://id.who.int/icd/release/11/mms XH6RP8 Hemangioma de células fusiformes http://id.who.int/icd/release/11/mms XH27G6 Hemangioma congénito, SAI http://id.who.int/icd/release/11/mms XH6RC4 Hemangioma congénito, rápidamente involutivo http://id.who.int/icd/release/11/mms XH5427 Hemangioma congénito, no involutivo http://id.who.int/icd/release/11/mms XH8PD3 Hemangioma tachuela http://id.who.int/icd/release/11/mms XH4LY5 Hemangioma capilar lobulillar http://id.who.int/icd/release/11/mms XH4E71 Hemangioendotelioma , maligno http://id.who.int/icd/release/11/mms XH6264 Hemangiosarcoma http://id.who.int/icd/release/11/mms XH36A5 Sarcoma de Kaposi http://id.who.int/icd/release/11/mms XH6FJ5 Sarcoma de células de Kupffer http://id.who.int/icd/release/11/mms XH3C78 Tumor alveolar bronquial intravascular http://id.who.int/icd/release/11/mms XH36H7 Sarcoma intimal http://id.who.int/icd/release/11/mms XH9GF8 Hemangioendotelioma epitelioide, SAI http://id.who.int/icd/release/11/mms XH4SY7 Angioendotelioma papilar intralinfático http://id.who.int/icd/release/11/mms XH6PA4 Hemangioendotelioma kaposiforme http://id.who.int/icd/release/11/mms XH2PS0 Hemangioendotelioma de células fusiformes http://id.who.int/icd/release/11/mms XH26F6 Hemangioendotelioma pseudomiogénico (tipo sarcoma epitelioide) http://id.who.int/icd/release/11/mms XH64U8 Hemangioendotelioma retiforme http://id.who.int/icd/release/11/mms XH8D24 Hemangioendotelioma compuesto http://id.who.int/icd/release/11/mms XH2L98 Hemangioendotelioma, SAI http://id.who.int/icd/release/11/mms XH6810 Hemangioblastoma http://id.who.int/icd/release/11/mms XH9ZB2 Adenolinfoma http://id.who.int/icd/release/11/mms XH1TX5 Papiloma glandular y de células escamosas mixtas http://id.who.int/icd/release/11/mms XH7J33 Linfadenoma http://id.who.int/icd/release/11/mms XH2PY4 Adenocarcinoma con metaplasia escamosa http://id.who.int/icd/release/11/mms XH7873 Carcinoma adenoescamoso http://id.who.int/icd/release/11/mms XH9JP2 Carcinoma epitelioma- mioepitelial http://id.who.int/icd/release/11/mms XH7247 Adenocarcinoma con metaplasia cartilaginosa y ósea http://id.who.int/icd/release/11/mms XH2QL8 Adenocarcinoma con metaplasia de células fusiformes http://id.who.int/icd/release/11/mms XH6G98 Carcinoma metaplásico semejante a la fibromatosis http://id.who.int/icd/release/11/mms XH4GA3 Adenocarcinoma con metaplasia apocrina http://id.who.int/icd/release/11/mms XH4T39 Adenocarcinoma con diferenciación neuroendocrina http://id.who.int/icd/release/11/mms XH0RD4 Carcinoma metaplásico, SAI http://id.who.int/icd/release/11/mms XH7MV6 Adenocarcinoma hepatoide http://id.who.int/icd/release/11/mms XH95Y6 Carcinoma ductal ecrino escamoide http://id.who.int/icd/release/11/mms XH8XD1 Carcinoma endometrioide con diferenciación escamosa http://id.who.int/icd/release/11/mms XH4ZH4 Adenomioma http://id.who.int/icd/release/11/mms XH7ZB1 Adenomioma polipoide atípico http://id.who.int/icd/release/11/mms XH6YS4 Nefroma quístico benigno http://id.who.int/icd/release/11/mms XH70N8 Siringoma condroide http://id.who.int/icd/release/11/mms XH8C13 Nódulo estromal endometrial http://id.who.int/icd/release/11/mms XH3SR2 Tumor renal osificante http://id.who.int/icd/release/11/mms XH2KC1 Adenoma pleomórfico http://id.who.int/icd/release/11/mms XH3470 Tumor renomedular de células intersticiales http://id.who.int/icd/release/11/mms XH2E97 Tumor estromal benigno http://id.who.int/icd/release/11/mms XH0533 Tumor estromal y epitelial mixto http://id.who.int/icd/release/11/mms XH7TJ0 Nefroma quístico pediátrico http://id.who.int/icd/release/11/mms XH5QU1 Adenomioepitelioma, SAI http://id.who.int/icd/release/11/mms XH2V57 Adenomioepitelioma, benigno http://id.who.int/icd/release/11/mms XH9T96 Tumor mesenquimal fosfatúrico, benigno http://id.who.int/icd/release/11/mms XH3UD9 Hamartoma pulmonar http://id.who.int/icd/release/11/mms XH3CQ8 Mioepitelioma http://id.who.int/icd/release/11/mms XH7AA3 Mesenquimoma, benigno http://id.who.int/icd/release/11/mms XH1SP3 Nefroma quístico del adulto http://id.who.int/icd/release/11/mms XH2P15 Hamartoma mesenquimatoso http://id.who.int/icd/release/11/mms XH1WZ6 Tumor condromixoide ectomesenquimatoso http://id.who.int/icd/release/11/mms XH5544 Adenosarcoma http://id.who.int/icd/release/11/mms XH1YV7 Carcinofibroma http://id.who.int/icd/release/11/mms XH42V2 Carcinoma ex adenoma pleomórfico http://id.who.int/icd/release/11/mms XH2RK1 Carcinosarcoma, embrionario http://id.who.int/icd/release/11/mms XH2CV3 Sarcoma del estroma endometrial de alto grado http://id.who.int/icd/release/11/mms XH1S94 Sarcoma del estroma endometrial, de bajo grado http://id.who.int/icd/release/11/mms XH9HQ1 Tumor estromal gastrointestinal http://id.who.int/icd/release/11/mms XH2WE3 Hepatoblastoma http://id.who.int/icd/release/11/mms XH0765 Sarcoma de células claras del riñón http://id.who.int/icd/release/11/mms XH64D5 Siringoma condroide maligno http://id.who.int/icd/release/11/mms XH9M31 Nefroma quístico maligno http://id.who.int/icd/release/11/mms XH3RF3 Tumor rabdoide, SAI http://id.who.int/icd/release/11/mms XH0Y65 Tumor mixto mesodérmico http://id.who.int/icd/release/11/mms XH7ZJ9 Tumor Mülleriano mixto http://id.who.int/icd/release/11/mms XH27L5 Pancreatoblastoma http://id.who.int/icd/release/11/mms XH2FY9 Blastoma pleuropulmonar http://id.who.int/icd/release/11/mms XH5VH1 Blastoma pulmonar http://id.who.int/icd/release/11/mms XH1TK5 Sarcoma estromal endometrial, SAI http://id.who.int/icd/release/11/mms XH49Y5 Sarcoma estromal, SAI http://id.who.int/icd/release/11/mms XH0V86 Tumor maligno,mixto, SAI http://id.who.int/icd/release/11/mms XH5QN3 Nefroblastoma, SAI http://id.who.int/icd/release/11/mms XH0H07 Hepatoblastoma, epitelioide http://id.who.int/icd/release/11/mms XH33R5 Hepatoblastoma epitelial mesenquimal mixto http://id.who.int/icd/release/11/mms XH2W45 Carcinosarcoma, SAI http://id.who.int/icd/release/11/mms XH7TL5 Adenomioepitelioma con carcinoma http://id.who.int/icd/release/11/mms XH3B27 Tumor mesenquimal fosfatúrico, maligno http://id.who.int/icd/release/11/mms XH43E6 Carcinoma mioepitelial http://id.who.int/icd/release/11/mms XH9N95 Mesenquimoma maligno http://id.who.int/icd/release/11/mms XH42Q2 Sarcoma embrionario http://id.who.int/icd/release/11/mms XH4VQ1 Gastroblastoma http://id.who.int/icd/release/11/mms XH5CT2 Tumor del nervio autonómico gastrointestinal http://id.who.int/icd/release/11/mms XH0712 Tumor de células del marcapaso gastrointestinal http://id.who.int/icd/release/11/mms XH1JB4 Nefroblastoma quístico parcialmente diferenciado http://id.who.int/icd/release/11/mms XH10F1 Nefroma mesoblástico http://id.who.int/icd/release/11/mms XH0G00 Sialoblastoma http://id.who.int/icd/release/11/mms XH6R49 Tumor estromal, SAI http://id.who.int/icd/release/11/mms XH4N88 Tumor estromal metanéfrico http://id.who.int/icd/release/11/mms XH8747 Tumor estromal de potencial maligno incierto http://id.who.int/icd/release/11/mms XH8X78 Tumor estromal epitelial anidado calcificante http://id.who.int/icd/release/11/mms XH2AD1 Mesenquimoma, SAI http://id.who.int/icd/release/11/mms XH5LL8 Tumor primitivo de células granulares no neurales http://id.who.int/icd/release/11/mms XH6ZU1 Cistadenoma de células claras http://id.who.int/icd/release/11/mms XH55F1 Tumor quístico del nódulo aurículo-ventricular http://id.who.int/icd/release/11/mms XH5232 Adenoma mucinoso intraductal papilar http://id.who.int/icd/release/11/mms XH4070 Tumor mucinoso intraductal papilar con displasia intermedia http://id.who.int/icd/release/11/mms XH8MD2 Tumor mucinoso intraductal papilarcon displasia de bajo grado http://id.who.int/icd/release/11/mms XH8ML6 Tumormucinoso intraductal papilar con displasia moderada http://id.who.int/icd/release/11/mms XH0556 Adenoma microquístico seroso http://id.who.int/icd/release/11/mms XH38C4 Papiloma seroso superficial http://id.who.int/icd/release/11/mms XH5RJ2 Cistadenoma, SAI http://id.who.int/icd/release/11/mms XH8TJ0 Cistadenoma seroso, SAI http://id.who.int/icd/release/11/mms XH0FM6 Cistadenoma papilar, SAI http://id.who.int/icd/release/11/mms XH6H73 Cistadenoma mucinoso, SAI http://id.who.int/icd/release/11/mms XH8XL1 Neoplasia quística mucinosa con displasia de grado intermedio http://id.who.int/icd/release/11/mms XH6NK7 Neoplasia quística mucinosa con displasia intraepitelial de bajo grado http://id.who.int/icd/release/11/mms XH7K36 Tumor quístico mucinoso con displasia intermedia http://id.who.int/icd/release/11/mms XH7834 Tumor quístico mucinoso con displasia moderada http://id.who.int/icd/release/11/mms XH0EK3 Neoplasia quística mucinosa con displasia de bajo grado http://id.who.int/icd/release/11/mms XH8EW6 Neoplasia quística mucinosa con neoplasia intraepitelial de grado intermedio http://id.who.int/icd/release/11/mms XH9BE7 Cistadenoma seromucinoso http://id.who.int/icd/release/11/mms XH2M29 Adenoma mucinoso http://id.who.int/icd/release/11/mms XH5RX2 Adenoma de las glándulas mucosas http://id.who.int/icd/release/11/mms XH9MS1 Cistadenofibroma papilar http://id.who.int/icd/release/11/mms XH5E08 Carcinoma mucinoso papilar intraductal, no invasivo http://id.who.int/icd/release/11/mms XH3MB3 Neoplasia mucinosa papilar intraductal con displasia de alto grado http://id.who.int/icd/release/11/mms XH06M2 Cistoadenocarcinoma mucinoso, no invasivo http://id.who.int/icd/release/11/mms XH81P3 Neoplasia quística mucinosa con displasia de alto grado http://id.who.int/icd/release/11/mms XH8PZ6 Carcinoma intraepitelial seroso http://id.who.int/icd/release/11/mms XH9DM1 Tumor borderline seroso, variante micropapilar http://id.who.int/icd/release/11/mms XH8NV8 Carcinoma intraepitelial tubárico seroso (CITS) http://id.who.int/icd/release/11/mms XH1YW4 Carcinoma intraepitelial endometrial seroso http://id.who.int/icd/release/11/mms XH5WU3 Carcinoma intraductal papilar-mucinoso, invasivo http://id.who.int/icd/release/11/mms XH2SE1 Neoplasia intraductal papilar-mucinoso, con carcinoma invasivo asociado http://id.who.int/icd/release/11/mms XH0572 Carcinoma seroso micropapilar http://id.who.int/icd/release/11/mms XH5P21 Carcinoma pseudopapilar sólido http://id.who.int/icd/release/11/mms XH0219 Cistadenocarcinoma, SAI http://id.who.int/icd/release/11/mms XH7A08 Carcinoma seroso, SAI http://id.who.int/icd/release/11/mms XH6JU6 Cistadenocarcinoma papilar, SAI http://id.who.int/icd/release/11/mms XH12V5 Carcinoma seroso de bajo grado http://id.who.int/icd/release/11/mms XH24N6 Carcinoma seroso de alto grado http://id.who.int/icd/release/11/mms XH1390 Cistoadenocarcinoma mucinoso, SAI http://id.who.int/icd/release/11/mms XH1K19 Tumor quístico mucinoso con un carcinoma invasivo asociado http://id.who.int/icd/release/11/mms XH4186 Carcinoma seromucinoso http://id.who.int/icd/release/11/mms XH1S75 Adenocarcinoma mucinoso http://id.who.int/icd/release/11/mms XH4U83 Pseudomixoma del peritoneo con sitio primario desconocido http://id.who.int/icd/release/11/mms XH5EQ2 Carcinoma mucinoso tubular y de células fusiformes http://id.who.int/icd/release/11/mms XH83J5 Pseudomixoma del peritoneo http://id.who.int/icd/release/11/mms XH4KC5 Carcinoma mucinoso tipo gástrico http://id.who.int/icd/release/11/mms XH56K0 Carcinoma de células de anillo de sello metastásico http://id.who.int/icd/release/11/mms XH5AF5 Adenocarcinoma productor de mucina http://id.who.int/icd/release/11/mms XH4546 Carcinoma de células en anillo de sello http://id.who.int/icd/release/11/mms XH2KK0 Carcinoma poco cohesivo http://id.who.int/icd/release/11/mms XH3RD4 Tumor de Krukenberg http://id.who.int/icd/release/11/mms XH0XE5 Carcinoma de células en anillo de sello / histiocitoide http://id.who.int/icd/release/11/mms XH3AE9 Neoplasia pseudopapilar sólido de páncreas http://id.who.int/icd/release/11/mms XH2FF0 Tumor quístico mucinosos de malignidad borderline http://id.who.int/icd/release/11/mms XH1P30 Cistadenoma papilar, de malignidad borderline http://id.who.int/icd/release/11/mms XH0RB9 Tumor borderline seromucinoso http://id.who.int/icd/release/11/mms XH3ZK9 Tumor seroso borderline, SAI http://id.who.int/icd/release/11/mms XH3FD4 Tumor de ovario pseudopapilar sólido http://id.who.int/icd/release/11/mms XH7BB4 Neoplasia mucinoso apendicular de bajo grado http://id.who.int/icd/release/11/mms XH6RX1 Neoplasia papilar intraquística con neoplasia intraepitelial de bajo grado http://id.who.int/icd/release/11/mms XH5ZH7 Neoplasia papilar intraductal con neoplasia intraepitelial de bajo grado http://id.who.int/icd/release/11/mms XH4LZ4 Papiloma intraductal http://id.who.int/icd/release/11/mms XH7QS7 Neoplasia intraductal tubular-papilar, bajo grado http://id.who.int/icd/release/11/mms XH6HK2 Neoplasia papilar intraductal, sin otra especificación http://id.who.int/icd/release/11/mms XH60S7 Papiloma intraductal con hiperplasia ductal atípica http://id.who.int/icd/release/11/mms XH7GN3 Adenoma del pezón http://id.who.int/icd/release/11/mms XH9F80 Adenoma papilar intraquístico http://id.who.int/icd/release/11/mms XH4JD3 Papilomatosis intraductal, sin otra especificación http://id.who.int/icd/release/11/mms XH8P86 Comedocarcinoma, no infiltrante http://id.who.int/icd/release/11/mms XH6AH7 Neoplasia papilar intraductal con neoplasia intraepitelial de alto grado http://id.who.int/icd/release/11/mms XH9VG0 Adenocarcinoma intraductal papilar no infiltrante http://id.who.int/icd/release/11/mms XH1H31 Carcinoma intraductal no infiltrante, SAI http://id.who.int/icd/release/11/mms XH4V32 Carcinoma ductal in situ, SAI http://id.who.int/icd/release/11/mms XH11S9 Papiloma intraductal con CDIS http://id.who.int/icd/release/11/mms XH64S7 Neoplasia papilar- tubular intraductal, de alto grado http://id.who.int/icd/release/11/mms XH9XV2 Carcinoma intraquístico no infiltrante http://id.who.int/icd/release/11/mms XH0134 Carcinoma papilar sólido in situ http://id.who.int/icd/release/11/mms XH39X8 Carcinoma intraductal, adherido, de alto grado http://id.who.int/icd/release/11/mms XH9SL6 Carcinoma hipersecretor quístico, intraductal http://id.who.int/icd/release/11/mms XH0GQ3 Carcinoma micropapilar intraductal http://id.who.int/icd/release/11/mms XH2HB2 Carcinoma lobular in situ, pleomórfico http://id.who.int/icd/release/11/mms XH6EH0 Carcinoma lobular in situ, sin otra especificación http://id.who.int/icd/release/11/mms XH7XE0 Carcinoma intraductal y carcinoma lobular in situ http://id.who.int/icd/release/11/mms XH3PE9 Neoplasia tubulopapilar intraductal http://id.who.int/icd/release/11/mms XH8010 Carcinoma in situ de glándulas sudoríparas endocrino productor de mucina http://id.who.int/icd/release/11/mms XH4US4 Papiloma intraductal con carcinoma lobulillar in situ http://id.who.int/icd/release/11/mms XH44J4 Carcinoma secretor http://id.who.int/icd/release/11/mms XH7KH3 Adenocarcinoma ductal, SAI http://id.who.int/icd/release/11/mms XH9FX2 Adenocarcinoma del tipo glándula mamaria http://id.who.int/icd/release/11/mms XH1N58 Comedocarcinoma, SAI http://id.who.int/icd/release/11/mms XH8MA7 Adenocarcinoma papilar intraductal con invasión http://id.who.int/icd/release/11/mms XH8KR8 Carcinoma papilar de la mama http://id.who.int/icd/release/11/mms XH90W1 Neoplasia papilar intraductal con carcinoma invasivo asociado http://id.who.int/icd/release/11/mms XH0GT6 Carcinoma papilar encapsulado con invasión http://id.who.int/icd/release/11/mms XH9C56 Carcinoma micropapilar invasivo de mama http://id.who.int/icd/release/11/mms XH1XB5 Carcinoma papilar sólido con invasión http://id.who.int/icd/release/11/mms XH2YP5 Carcinoma medular, SAI http://id.who.int/icd/release/11/mms XH9B99 Carcinoma parecido al medular http://id.who.int/icd/release/11/mms XH2XR3 Carcinoma lobular, SAI http://id.who.int/icd/release/11/mms XH9620 Adenocarcinoma medular http://id.who.int/icd/release/11/mms XH6KZ1 Carcinoma medular atípico http://id.who.int/icd/release/11/mms XH6PY4 Carcinoma del conducto, tipo desmoplásico http://id.who.int/icd/release/11/mms XH55H7 Carcinoma medular con estroma linfoide http://id.who.int/icd/release/11/mms XH3RK9 Carcinoma tubulolobular http://id.who.int/icd/release/11/mms XH0408 Carcinoma ductal infiltrante http://id.who.int/icd/release/11/mms XH8RN5 Carcinoma infiltrante del conducto y lobular http://id.who.int/icd/release/11/mms XH9Z29 Carcinoma lobular e intraductal http://id.who.int/icd/release/11/mms XH6MH3 Carcinoma infiltrante ductal y carcinoma in situ lobular http://id.who.int/icd/release/11/mms XH9551 Carcinoma infiltrante lobular y carcinoma ductal insitu http://id.who.int/icd/release/11/mms XH8CS0 Carcinoma infiltrante ductal mezclado con otros tipos de carcinoma http://id.who.int/icd/release/11/mms XH9GX4 Carcinoma infiltrante ductal carcinoma coloide http://id.who.int/icd/release/11/mms XH2ST9 Carcinoma cribiforme y ductal infiltrante http://id.who.int/icd/release/11/mms XH3969 Carcinoma ductal y mucinoso infiltrante http://id.who.int/icd/release/11/mms XH1ND7 Carcinoma infiltrante ductal y tubular http://id.who.int/icd/release/11/mms XH3CB4 Infiltración lobular mezclada con otros tipos de carcinoma http://id.who.int/icd/release/11/mms XH5SD5 Adenocarcinoma polimorfo http://id.who.int/icd/release/11/mms XH9G73 Carcinoma inflamatorio http://id.who.int/icd/release/11/mms XH3E21 Enfermedad de Paget, mamaria http://id.who.int/icd/release/11/mms XH47A6 Enfermedad de Paget y carcinoma infiltrante de conducto de mama http://id.who.int/icd/release/11/mms XH70F8 Enfermedad de Paget , extramamaria http://id.who.int/icd/release/11/mms XH0C76 Enfermedad de Paget y carcinoma intraductal de mama http://id.who.int/icd/release/11/mms XH32K6 Carcinoma de mama similar al basal http://id.who.int/icd/release/11/mms XH4ZU9 Adenocarcinoma de glándulas anogenitales similares a las mamarias http://id.who.int/icd/release/11/mms XH5KW8 Carcinoma de mama masculino http://id.who.int/icd/release/11/mms XH4EK4 Carcinoma endocrino de glándulas sudoríparas productor de mucina http://id.who.int/icd/release/11/mms XH9HB7 Carcinoma lobular pleomórfico http://id.who.int/icd/release/11/mms XH1146 Carcinoma juvenil de la mama http://id.who.int/icd/release/11/mms XH8TH6 Carcinoma quístico hipersecretor http://id.who.int/icd/release/11/mms XH9HV0 Tumor epitelial, benigno http://id.who.int/icd/release/11/mms XH1TD2 Tumorlet, benigno http://id.who.int/icd/release/11/mms XH65S3 Epitelioma, benigno http://id.who.int/icd/release/11/mms XH0M86 Hiperplasia nodular focal http://id.who.int/icd/release/11/mms XH5NV6 Carcinoma in situ, SAI http://id.who.int/icd/release/11/mms XH56X7 Carcinoma con células gigantes como osteoclastos http://id.who.int/icd/release/11/mms XH63D2 Carcinoma SAI http://id.who.int/icd/release/11/mms XH3XZ6 Carcinoma de células gigantes y células fusiformes http://id.who.int/icd/release/11/mms XH1JZ2 Carcinoma de células gigantes http://id.who.int/icd/release/11/mms XH00N7 Carcinoma de células vítreas http://id.who.int/icd/release/11/mms XH4QU2 Carcinoma de células grandes con fenotipo rabdoide http://id.who.int/icd/release/11/mms XH0NL5 Carcinoma neuroendocrino de células grandes http://id.who.int/icd/release/11/mms XH35G0 Carcinoma pleomórfico http://id.who.int/icd/release/11/mms XH92T7 Carcinoma de células poligonales http://id.who.int/icd/release/11/mms XH35M3 Carcinoma pseudosarcomatoso http://id.who.int/icd/release/11/mms XH1YN3 Carcinoma, metastásico, SAI http://id.who.int/icd/release/11/mms XH8D74 Carcinomatosis http://id.who.int/icd/release/11/mms XH4P61 Epitelioma maligno http://id.who.int/icd/release/11/mms XH45J4 Carcinoma de células grandes, SAI http://id.who.int/icd/release/11/mms XH1YY4 Carcinoma indiferenciado, SAI http://id.who.int/icd/release/11/mms XH57U9 Carcinoma, anaplásico, SAI http://id.who.int/icd/release/11/mms XH2855 Proteína nuclear en los testículos (NUT) asociada a carcinoma http://id.who.int/icd/release/11/mms XH3RZ4 Carcinoma de células fusiformes, SAI http://id.who.int/icd/release/11/mms XH0YB0 Carcinoma de células pequeñas, SAI http://id.who.int/icd/release/11/mms XH9SY0 Carcinoma neuroendocrino de células pequeñas http://id.who.int/icd/release/11/mms XH28J9 Carcinoma de células de avena http://id.who.int/icd/release/11/mms XH3T00 Carcinoma de células pequeñas, células fusiformes http://id.who.int/icd/release/11/mms XH6GK0 Carcinoma de células pequeñas, células intermedias http://id.who.int/icd/release/11/mms XH8ZR8 Carcinoma de células pequeñas, tipo hipercalcémico http://id.who.int/icd/release/11/mms XH7YE3 Carcinoma combinado de células pequeñas http://id.who.int/icd/release/11/mms XH0793 Adenocarcinoma combinado de células pequeñas http://id.who.int/icd/release/11/mms XH6FK9 Carcinoma combinado de células pequeñas y células grandes http://id.who.int/icd/release/11/mms XH9ZD2 Carcinoma combinado de células pequeñas y escamosas http://id.who.int/icd/release/11/mms XH1DU4 Carcinoma de células no pequeñas http://id.who.int/icd/release/11/mms XH26N1 Carcinoma asociado a heterotopía http://id.who.int/icd/release/11/mms XH90B3 Carcinoma combinado neuroendocrino de células grandes http://id.who.int/icd/release/11/mms XH98Z7 Carcinoma anaplásico indiferenciado http://id.who.int/icd/release/11/mms XH5R16 Carcinoma desdiferenciado http://id.who.int/icd/release/11/mms XH2BS4 Carcinoma escamoso con células gigantes parecidas a osteoclastos http://id.who.int/icd/release/11/mms XH2224 Carcinoma indiferenciado con células gigantes parecidas a osteoclastos http://id.who.int/icd/release/11/mms XH1N44 Tumourlet, SAI http://id.who.int/icd/release/11/mms XH5DX3 Tumor de Brenner, SAI http://id.who.int/icd/release/11/mms XH4MA6 Fibroadenoma intracanalicular http://id.who.int/icd/release/11/mms XH7JU0 Adenofibroma papilar http://id.who.int/icd/release/11/mms XH0N11 Fibroadenoma pericanalicular http://id.who.int/icd/release/11/mms XH9HE2 Fibroadenoma, SAI http://id.who.int/icd/release/11/mms XH91Y8 Adenofibroma, SAI http://id.who.int/icd/release/11/mms XH5S99 Cistadenofibroma, SAI http://id.who.int/icd/release/11/mms XH5ZB5 Adenofibroma seroso, SAI http://id.who.int/icd/release/11/mms XH6RL8 Cistadenofibroma seroso, SAI http://id.who.int/icd/release/11/mms XH1VJ0 Adenofibroma seromucinoso http://id.who.int/icd/release/11/mms XH59X8 Adenofibroma mucinoso, SAI http://id.who.int/icd/release/11/mms XH9SM7 Cistadenofibroma mucinoso, SAI http://id.who.int/icd/release/11/mms XH50P7 Tumor filoide, benigno http://id.who.int/icd/release/11/mms XH4RU1 Fibroadenoma gigante http://id.who.int/icd/release/11/mms XH70H4 Fibroadenoma juvenil http://id.who.int/icd/release/11/mms XH5853 Lipofibroadenoma http://id.who.int/icd/release/11/mms XH7ZU2 Adenofibroma metanéfrico http://id.who.int/icd/release/11/mms XH6NJ7 Tumor de Brenner, maligno http://id.who.int/icd/release/11/mms XH7284 Adenocarcinofibroma mucinoso http://id.who.int/icd/release/11/mms XH75P5 Tumor estromal periductal, bajo grado http://id.who.int/icd/release/11/mms XH9JC2 Adenocarcinofibroma seroso http://id.who.int/icd/release/11/mms XH6PQ0 Cistadenocarcinofibroma seroso http://id.who.int/icd/release/11/mms XH0WW5 Cistadenocarcinofibroma mucinoso http://id.who.int/icd/release/11/mms XH8HJ7 Tumor filoides, maligno http://id.who.int/icd/release/11/mms XH2CH8 Tumor de Brenner, malignidad borderline http://id.who.int/icd/release/11/mms XH7AR7 Adenofibroma mucinoso de malignidad borferline http://id.who.int/icd/release/11/mms XH2YZ1 Cistadenofibroma mucinoso de malignidad borderline http://id.who.int/icd/release/11/mms XH5NK4 Tumor filoides, borderline http://id.who.int/icd/release/11/mms XH07C7 Adenofibroma seroso de malignidad borderline http://id.who.int/icd/release/11/mms XH2M30 Cistadenofibroma seroso de malignidad borderline http://id.who.int/icd/release/11/mms XH8A47 Angiomiofibroblastoma http://id.who.int/icd/release/11/mms XH06N0 Histiocitoma fibroso benigno http://id.who.int/icd/release/11/mms XH3BQ8 Elastofibroma http://id.who.int/icd/release/11/mms XH2MW3 Fibroma fascial http://id.who.int/icd/release/11/mms XH5XQ3 Fibromixoma http://id.who.int/icd/release/11/mms XH3NQ0 Miofibroblastoma http://id.who.int/icd/release/11/mms XH0953 Miofibroma http://id.who.int/icd/release/11/mms XH7FV0 Fibroma periosteal http://id.who.int/icd/release/11/mms XH8E66 Fibroma, SAI http://id.who.int/icd/release/11/mms XH2ZF3 Fibroblastoma desmoplástica http://id.who.int/icd/release/11/mms XH7GT0 Fibroma de Gardner http://id.who.int/icd/release/11/mms XH0XH6 Fibroma Nuchal http://id.who.int/icd/release/11/mms XH2WT6 Fibromixoma plexiforme http://id.who.int/icd/release/11/mms XH0WB3 Fibroma de la vaina del tendón http://id.who.int/icd/release/11/mms XH8Q71 Tumor fibroso solitario / Hemangiopericitoma, grado 1 http://id.who.int/icd/release/11/mms XH7TH6 Tumor fibroso calcificante http://id.who.int/icd/release/11/mms XH5LM1 Facitis nodular http://id.who.int/icd/release/11/mms XH1UJ5 Histiocitoma, SAI http://id.who.int/icd/release/11/mms XH8B90 Dermatofibroma, SAI http://id.who.int/icd/release/11/mms XH7436 Neumocitoma esclerosante http://id.who.int/icd/release/11/mms XH5DP4 Histiocitoma profundo http://id.who.int/icd/release/11/mms XH9VG1 Histiocitoma juvenil http://id.who.int/icd/release/11/mms XH33Q1 Reticulohistiocitoma http://id.who.int/icd/release/11/mms XH8ZE3 Fibroma aponeurótico calcificante http://id.who.int/icd/release/11/mms XH2874 Fibroma colagenoso http://id.who.int/icd/release/11/mms XH3665 Fibroma dérmico como placa CD34 positivo http://id.who.int/icd/release/11/mms XH8173 Fibromixoma acral http://id.who.int/icd/release/11/mms XH5JG7 Fibroma esclerótico http://id.who.int/icd/release/11/mms XH6JX7 Fascitis proliferativa http://id.who.int/icd/release/11/mms XH87F9 Miositis proliferativa http://id.who.int/icd/release/11/mms XH15M9 Histiocitoma fibroso epitelioide http://id.who.int/icd/release/11/mms XH1BV2 Fibroma pleomorfo http://id.who.int/icd/release/11/mms XH18K3 Dermatomiofibroma http://id.who.int/icd/release/11/mms XH2HE9 Miopericitoma http://id.who.int/icd/release/11/mms XH5FY2 Displasia fibrosa http://id.who.int/icd/release/11/mms XH8EV4 Fibrosarcoma de la fascia http://id.who.int/icd/release/11/mms XH6LT0 Fibromixosarcoma http://id.who.int/icd/release/11/mms XH7BC6 Fibrosarcoma infantil http://id.who.int/icd/release/11/mms XH3406 Fibrosarcoma periosteal http://id.who.int/icd/release/11/mms XH56W2 Sarcoma periosteal, SAI http://id.who.int/icd/release/11/mms XH1HP3 Tumor fibroso solitario, maligno http://id.who.int/icd/release/11/mms XH4EP1 Fibrosarcoma, SAI http://id.who.int/icd/release/11/mms XH1DA3 Tumor fibroso solitario / Haemangiopericitoma, grado 3 http://id.who.int/icd/release/11/mms XH2668 Sarcoma miofibroblástico http://id.who.int/icd/release/11/mms XH0947 Histiocitoma fibroso maligno http://id.who.int/icd/release/11/mms XH8WH0 Mixofibrosarcoma http://id.who.int/icd/release/11/mms XH9V92 Dermatofibrosarcoma protuberans, fibrosarcomatoso http://id.who.int/icd/release/11/mms XH6116 Fibromatosis abdominal http://id.who.int/icd/release/11/mms XH13Z3 Fibromatosis agresiva http://id.who.int/icd/release/11/mms XH1RM7 Histiocitoma fibroso atípico http://id.who.int/icd/release/11/mms XH9HH5 Fibroma celular http://id.who.int/icd/release/11/mms XH5MH2 Fibromatosis congénita generalizada http://id.who.int/icd/release/11/mms XH85R1 Tumor miofibroblástico, peribronquial http://id.who.int/icd/release/11/mms XH1N00 Miofibromatosis http://id.who.int/icd/release/11/mms XH2D15 Sarcoma fibroblástico mixoinflamatorio http://id.who.int/icd/release/11/mms XH0TA8 Tumor fibroblástico mixoinflamatorio atípico http://id.who.int/icd/release/11/mms XH9526 Tumor fibrolipomatoso hemosiderótico http://id.who.int/icd/release/11/mms XH75J5 Fibromatosis de tipo palmar / plantar http://id.who.int/icd/release/11/mms XH7E62 Tumor fibroso solitario, SAI http://id.who.int/icd/release/11/mms XH1EH1 Tumor fibroso solitario / Haemangiopericitoma, grado 2 http://id.who.int/icd/release/11/mms XH66Z0 Tumor miofibroblástico, SAI http://id.who.int/icd/release/11/mms XH6YK5 Fibroma desmoplásico http://id.who.int/icd/release/11/mms XH4QZ8 Dermatofibrosarcoma protuberante, SAI http://id.who.int/icd/release/11/mms XH5CT4 Dermatofibrosarcoma protuberans pigmentado http://id.who.int/icd/release/11/mms XH9AV8 Fibroblastoma de células gigantes http://id.who.int/icd/release/11/mms XH4GL1 Tumor fibrohistiocítico plexiforme http://id.who.int/icd/release/11/mms XH9362 Histiocitoma fibroso angiomatoso http://id.who.int/icd/release/11/mms XH7050 Hemangiopericitoma meningioma http://id.who.int/icd/release/11/mms XH3GV5 Teratoma, benigno http://id.who.int/icd/release/11/mms XH9F67 Quiste dermoide, SAI http://id.who.int/icd/release/11/mms XH52Q4 Teratoma, tipo prepuberal http://id.who.int/icd/release/11/mms XH22M4 Struma del ovario, SAI http://id.who.int/icd/release/11/mms XH8AD3 Células germinales malignas intratubulares http://id.who.int/icd/release/11/mms XH24E0 Disgerminoma http://id.who.int/icd/release/11/mms XH0A34 Tumor de células germinales, no seminomatoso http://id.who.int/icd/release/11/mms XH1E13 Germinoma http://id.who.int/icd/release/11/mms XH7SG5 Tumor hepatoide del saco vitelino http://id.who.int/icd/release/11/mms XH0N49 Teratoma inmaduro, maligno http://id.who.int/icd/release/11/mms XH2PP9 Teratoma maligno, indiferenciado http://id.who.int/icd/release/11/mms XH9Z28 Poliembrioma http://id.who.int/icd/release/11/mms XH6YQ4 Seminoma, anaplásico http://id.who.int/icd/release/11/mms XH80D1 Seminoma espermatocítico http://id.who.int/icd/release/11/mms XH56W1 Teratocarcinoma http://id.who.int/icd/release/11/mms XH09W7 Tumor de saco vitelino http://id.who.int/icd/release/11/mms XH9FM4 Seminoma, SAI http://id.who.int/icd/release/11/mms XH8MB9 Carcinoma embrionario, SAI http://id.who.int/icd/release/11/mms XH15X1 Tumor del saco vitelino, tipo pospúberal http://id.who.int/icd/release/11/mms XH7YZ9 Teratoma maligno, SAI http://id.who.int/icd/release/11/mms XH43T4 Teratoma maligno, intermedio http://id.who.int/icd/release/11/mms XH33E8 Teratoma con transformación maligna http://id.who.int/icd/release/11/mms XH2PS1 Tumor de células germinales mixtas http://id.who.int/icd/release/11/mms XH9QP9 Tumor de células germinales asociado con malignidad hematológica http://id.who.int/icd/release/11/mms XH5U02 Teratoma mixto y seminoma http://id.who.int/icd/release/11/mms XH5PU7 Struma del ovario, maligno http://id.who.int/icd/release/11/mms XH1P78 Teratocarcinosarcoma http://id.who.int/icd/release/11/mms XH0K61 Gonadoblastoma http://id.who.int/icd/release/11/mms XH83G5 Teratoma, SAI http://id.who.int/icd/release/11/mms XH4NU1 Tumor de células germinales, regresivo http://id.who.int/icd/release/11/mms XH5MG2 Teratoma inmaduro del pulmón http://id.who.int/icd/release/11/mms XH2KP9 Teratoma inmaduro del timo http://id.who.int/icd/release/11/mms XH2XW3 Carcinoma estromal http://id.who.int/icd/release/11/mms XH5PC3 Teratoma inmaduro de tiroides http://id.who.int/icd/release/11/mms XH6911 Tumor de células gigantes tenosinoviales, localizado http://id.who.int/icd/release/11/mms XH0HZ1 Tumor de células gigantes tenosinoviales, SAI http://id.who.int/icd/release/11/mms XH0492 Tumor de hueso de células gigantes, maligno http://id.who.int/icd/release/11/mms XH84X1 Tumor maligno de células gigantes de partes blandas http://id.who.int/icd/release/11/mms XH4TC2 Tumor de células gigantes de hueso, SAI http://id.who.int/icd/release/11/mms XH81M1 Tumor de células gigantes de partes blandas, SAI http://id.who.int/icd/release/11/mms XH52J9 Tumor de células gigantes tenosinovial, difuso http://id.who.int/icd/release/11/mms XH5AQ9 Tumor de células gigantes tenosinoviales malignas http://id.who.int/icd/release/11/mms XH0RF9 Papiloma de plexo coroideo, SAI http://id.who.int/icd/release/11/mms XH0H76 Tumor neuroepitelial disembrioplásico. http://id.who.int/icd/release/11/mms XH1Q28 Ependimoma selar http://id.who.int/icd/release/11/mms XH1DC5 Astroblastoma http://id.who.int/icd/release/11/mms XH96C7 Astrocitoma, anaplásico http://id.who.int/icd/release/11/mms XH1S63 Astrocitoma, de bajo grado http://id.who.int/icd/release/11/mms XH54D9 Ependimoma celular http://id.who.int/icd/release/11/mms XH3M77 Carcinoma de plexos coroides http://id.who.int/icd/release/11/mms XH6E51 Ependimoma de células claras http://id.who.int/icd/release/11/mms XH8W32 Astrocitoma difuso http://id.who.int/icd/release/11/mms XH6UY7 Astrocitoma difuso, de bajo grado http://id.who.int/icd/release/11/mms XH6922 Ependimoma anaplásico http://id.who.int/icd/release/11/mms XH6C35 Astrocitoma fibrilar http://id.who.int/icd/release/11/mms XH5Y81 Astrocitoma gemistocítico http://id.who.int/icd/release/11/mms XH4RQ3 Glioma, maligno http://id.who.int/icd/release/11/mms XH6ZH4 Gliomatosis cerebral http://id.who.int/icd/release/11/mms XH9RC8 Gliosarcoma http://id.who.int/icd/release/11/mms XH6F49 Oligoastrocitoma, SAI http://id.who.int/icd/release/11/mms XH9J28 Ependimoma papilar http://id.who.int/icd/release/11/mms XH99U2 Xantoastrocitoma pleomórfico http://id.who.int/icd/release/11/mms XH6UV4 Astrocitoma protoplásmico http://id.who.int/icd/release/11/mms XH4BJ4 Ependimoma tanicítico http://id.who.int/icd/release/11/mms XH7692 Glioma difuso de la línea media, mutante H3 K27M http://id.who.int/icd/release/11/mms XH9YU2 Gliomas pontino intrínseco difuso, mutante H3 K27M http://id.who.int/icd/release/11/mms XH1511 Ependimoma, SAI http://id.who.int/icd/release/11/mms XH2AY7 Ependimoma RELA fusión positiva http://id.who.int/icd/release/11/mms XH6PH6 Astrocitoma, SAI http://id.who.int/icd/release/11/mms XH36Y8 Astrocitoma quístico http://id.who.int/icd/release/11/mms XH2HK4 Astrocitoma difuso, IDH mutante http://id.who.int/icd/release/11/mms XH7HQ6 Astrocitoma anaplásico, IDH mutante http://id.who.int/icd/release/11/mms XH83Y5 Espongioblastoma polar http://id.who.int/icd/release/11/mms XH8BK8 Xantoastrocitoma pleomórfico anaplásico http://id.who.int/icd/release/11/mms XH7F82 Glioblastoma, SAI http://id.who.int/icd/release/11/mms XH5571 Glioblastoma, IDH- de tipo salvaje http://id.who.int/icd/release/11/mms XH0MB1 Glioblastoma, primario SAI http://id.who.int/icd/release/11/mms XH3N49 Glioma difuso de la línea media, SAI http://id.who.int/icd/release/11/mms XH61Y5 Glioma pontino intrínseco difuso http://id.who.int/icd/release/11/mms XH4FN3 Glioblastoma, IDH mutante http://id.who.int/icd/release/11/mms XH17J4 Glioblastoma, secundario, SAI http://id.who.int/icd/release/11/mms XH7W59 Oligodendroglioma, SAI http://id.who.int/icd/release/11/mms XH7K31 Oligodendroglioma, IDH mutante y co deleción 1p/19q http://id.who.int/icd/release/11/mms XH9QF3 Oligodendroglioma, anaplásico IDH mutante y co deleción 1p/19q http://id.who.int/icd/release/11/mms XH7CX7 Oligodendroblastoma http://id.who.int/icd/release/11/mms XH8P29 Meduloblastoma, SAI http://id.who.int/icd/release/11/mms XH9M38 Meduloblastoma, SHH-activado y TP53 tipo salvaje http://id.who.int/icd/release/11/mms XH8844 Oligodendroglioma, anaplásico http://id.who.int/icd/release/11/mms XH4B47 Meduloblastoma melanótico http://id.who.int/icd/release/11/mms XH6JN6 Meduloblastoma con nodularidad extensa http://id.who.int/icd/release/11/mms XH85M7 Meduloblastoma, SHH activado, SAI http://id.who.int/icd/release/11/mms XH8SH6 Tumor embrionario del Sistema nervioso central, SAI http://id.who.int/icd/release/11/mms XH89C3 Tumor neuroectodérmico primitivo central http://id.who.int/icd/release/11/mms XH3EX1 Meduloblastoma, WNT activado, clásico http://id.who.int/icd/release/11/mms XH5163 Meduloblastoma, WNT activado, tipo células grandes http://id.who.int/icd/release/11/mms XH2FW8 Meduloblastoma, WNT activado, tipo Anaplásico http://id.who.int/icd/release/11/mms XH1SH4 Meduloblastoma, SHH-activado y TP53- mutante http://id.who.int/icd/release/11/mms XH87Q5 Meduloblastoma, no WNT/ no SHH http://id.who.int/icd/release/11/mms XH51C5 Tumores embrionarios con rosetones de múltiples capas con alteración C19MC http://id.who.int/icd/release/11/mms XH0KZ2 Tumor embrionario con rosetas de múltiples capas, SAI http://id.who.int/icd/release/11/mms XH5538 Sarcoma cerebeloso, SAI http://id.who.int/icd/release/11/mms XH8R14 Medulomioblastoma http://id.who.int/icd/release/11/mms XH7Y86 TNEP Supratentorial http://id.who.int/icd/release/11/mms XH5PR7 Meduloblastoma de células grandes http://id.who.int/icd/release/11/mms XH0H95 Meduloblastoma anaplásico http://id.who.int/icd/release/11/mms XH8UC5 Glioblastoma de células gigantes http://id.who.int/icd/release/11/mms XH0RY1 Meduloblastoma clásico http://id.who.int/icd/release/11/mms XH7PN5 Meduloblastoma desmoplásico/nodular http://id.who.int/icd/release/11/mms XH3904 Tumor papilar de la región pineal http://id.who.int/icd/release/11/mms XH2C49 Astrocitoma difuso, tipo salvaje-IDH http://id.who.int/icd/release/11/mms XH2BA5 Glioblastoma epitelioide http://id.who.int/icd/release/11/mms XH0ZP6 Meduloblastoma, WNT activado, SAI http://id.who.int/icd/release/11/mms XH5XD3 Meduloblastoma, grupo 3 http://id.who.int/icd/release/11/mms XH25R4 Meduloblastoma, grupo 4 http://id.who.int/icd/release/11/mms XH39Z7 Astrocitoma, anaplásico, tipo salvaje IDH http://id.who.int/icd/release/11/mms XH17F8 Glioma difuso de bajo grado, vía MAPK alterada http://id.who.int/icd/release/11/mms XH2SS9 Glioma hemisférico difuso, mutante H3 G34 http://id.who.int/icd/release/11/mms XH4Q01 Glioma difuso de alto grado de tipo pediátrico, tipo salvaje H3 y tipo salvaje IDH http://id.who.int/icd/release/11/mms XH4ZM8 Glioma hemisférico de tipo infantil http://id.who.int/icd/release/11/mms XH12D2 Astrocitoma pilocítico http://id.who.int/icd/release/11/mms XH29Q5 Astrocitoma pilomixoide http://id.who.int/icd/release/11/mms XH41C5 Glioma angiocéntrico http://id.who.int/icd/release/11/mms XH3Y57 Papiloma de plexos coroides atípico http://id.who.int/icd/release/11/mms XH7M44 Astrocitoma infantil desmoplásico http://id.who.int/icd/release/11/mms XH6TQ7 Ganglioglioma infantil desmoplástico http://id.who.int/icd/release/11/mms XH0B58 Gliofibroma http://id.who.int/icd/release/11/mms XH6738 Ependimoma- subependimoma mixto http://id.who.int/icd/release/11/mms XH15U1 Ependimoma mixopapilar http://id.who.int/icd/release/11/mms XH1L48 Astrocitoma de células gigantes subepedimales http://id.who.int/icd/release/11/mms XH8FZ9 Subependimoma http://id.who.int/icd/release/11/mms XH59V4 Pituicitoma http://id.who.int/icd/release/11/mms XH9HV1 Glioma cordoide http://id.who.int/icd/release/11/mms XH4101 Glioma cordoide del tercer ventrículo http://id.who.int/icd/release/11/mms XH09A9 Tumor de células granulares, SAI http://id.who.int/icd/release/11/mms XH2XW8 Tumor de células granulares de la región selar http://id.who.int/icd/release/11/mms XH8V95 Sarcoma alveolar de partes blandas http://id.who.int/icd/release/11/mms XH90D3 Tumor de células granulares, maligno http://id.who.int/icd/release/11/mms XH2SJ1 Fibrolipoma http://id.who.int/icd/release/11/mms XH0PH8 Fibromixolipoma http://id.who.int/icd/release/11/mms XH7TB0 Angiolipoma infiltrante http://id.who.int/icd/release/11/mms XH5GN5 Lipoma infiltrante http://id.who.int/icd/release/11/mms XH3TE0 Lipoma intramuscular http://id.who.int/icd/release/11/mms XH30M7 Lipoma pleomórfico http://id.who.int/icd/release/11/mms XH4E98 Lipoma de células fusiformes http://id.who.int/icd/release/11/mms XH1PL8 Lipoma, SAI http://id.who.int/icd/release/11/mms XH4G31 Timolipoma http://id.who.int/icd/release/11/mms XH3C77 Angiolipoma, SAI http://id.who.int/icd/release/11/mms XH4VB4 Angiomiolipoma http://id.who.int/icd/release/11/mms XH7WX8 Lipoma condroide http://id.who.int/icd/release/11/mms XH17C5 Mielolipoma http://id.who.int/icd/release/11/mms XH1054 Hibernoma http://id.who.int/icd/release/11/mms XH8L55 Lipoblastomatosis http://id.who.int/icd/release/11/mms XH1C03 Liposarcoma desdiferenciado http://id.who.int/icd/release/11/mms XH6R46 Liposarcoma fibroblastico http://id.who.int/icd/release/11/mms XH7PE7 Liposarcoma inflamatorio http://id.who.int/icd/release/11/mms XH7Y61 Liposarcoma bien diferenciado http://id.who.int/icd/release/11/mms XH8VG3 Liposarcoma mixto http://id.who.int/icd/release/11/mms XH3EL0 Liposarcoma mixoide http://id.who.int/icd/release/11/mms XH25R1 Liposarcoma pleomórfico http://id.who.int/icd/release/11/mms XH8D43 Liposarcoma esclerosante http://id.who.int/icd/release/11/mms XH2J05 Liposarcoma, SAI http://id.who.int/icd/release/11/mms XH0RW4 Tumor lipomatoso atípico http://id.who.int/icd/release/11/mms XH4QB6 Lipofibromatosis http://id.who.int/icd/release/11/mms XH0QR3 Angiomiolipoma, Epitelioide http://id.who.int/icd/release/11/mms XH9MR8 Linfangioma, SAI http://id.who.int/icd/release/11/mms XH6LF7 Linfangioma capilar http://id.who.int/icd/release/11/mms XH2EU7 Linfangioma cavernoso http://id.who.int/icd/release/11/mms XH8G00 Linfangioma quístico http://id.who.int/icd/release/11/mms XH2DS9 Linfangiomioma http://id.who.int/icd/release/11/mms XH62A3 Hemolinfangioma http://id.who.int/icd/release/11/mms XH10U6 Linfangiosarcoma http://id.who.int/icd/release/11/mms XH10K6 Linfangiomiomatosis http://id.who.int/icd/release/11/mms XH5ZC7 Meningioma fibroso http://id.who.int/icd/release/11/mms XH0R11 Meningioma rico en linfoplasmacitos http://id.who.int/icd/release/11/mms XH11P5 Meningioma, SAI http://id.who.int/icd/release/11/mms XH40T5 Meningioma meningotelial http://id.who.int/icd/release/11/mms XH7N06 Meningioma metaplásico http://id.who.int/icd/release/11/mms XH1F70 Meningioma microcístico http://id.who.int/icd/release/11/mms XH6Z51 Meningioma http://id.who.int/icd/release/11/mms XH3L73 Meningioma, hemangioblástico http://id.who.int/icd/release/11/mms XH4ZM7 Meningioma psammomatoso http://id.who.int/icd/release/11/mms XH6L68 Meningioma, angiomatoso http://id.who.int/icd/release/11/mms XH4EX5 Meningioma, transicional http://id.who.int/icd/release/11/mms XH0324 Meningioma, maligno http://id.who.int/icd/release/11/mms XH2NY9 Meningioma papilar http://id.who.int/icd/release/11/mms XH6QS9 Meningioma rabdoide http://id.who.int/icd/release/11/mms XH5976 Sarcomatosis meningea http://id.who.int/icd/release/11/mms XH71V9 Meningioma de células claras http://id.who.int/icd/release/11/mms XH2LS4 Meningioma coroideo http://id.who.int/icd/release/11/mms XH1PF6 Meningioma atípico http://id.who.int/icd/release/11/mms XH3SX7 Adenoma de ovario neto http://id.who.int/icd/release/11/mms XH5AH3 Mesonefroma, benigno http://id.who.int/icd/release/11/mms XH71B5 Adenocarcinoma de ovario neto http://id.who.int/icd/release/11/mms XH5WG5 Mesonefroma, maligno http://id.who.int/icd/release/11/mms XH2WJ5 Tumor Wolffiano http://id.who.int/icd/release/11/mms XH2VV6 Mesotelioma fibroso, benigno http://id.who.int/icd/release/11/mms XH1SS1 Mesotelioma benigno http://id.who.int/icd/release/11/mms XH0KC4 Mesotelioma epitelioide benigno http://id.who.int/icd/release/11/mms XH67N8 Mesotelioma papilar bien diferenciado http://id.who.int/icd/release/11/mms XH8U12 Quistes de inclusión peritoneales http://id.who.int/icd/release/11/mms XH6BY3 Tumor adenomatoide, SAI http://id.who.int/icd/release/11/mms XH54S8 Mesotelioma fibroso, maligno http://id.who.int/icd/release/11/mms XH0XV0 Mesotelioma, maligno http://id.who.int/icd/release/11/mms XH1DX8 Mesotelioma, bifásico, maligno http://id.who.int/icd/release/11/mms XH0VP5 Mesotelioma epitelioide, maligno http://id.who.int/icd/release/11/mms XH85T6 Mesotelioma papilar bien diferenciado de la pleura http://id.who.int/icd/release/11/mms XH6M86 Fibroma osificante http://id.who.int/icd/release/11/mms XH23E0 Quiste óseo aneurismático http://id.who.int/icd/release/11/mms XH8F52 Adamantinoma de los huesos largos http://id.who.int/icd/release/11/mms XH6C72 Tumor neuroectodérmico melanótico http://id.who.int/icd/release/11/mms XH7MT7 Tumor de células de la notocorda benigno http://id.who.int/icd/release/11/mms XH0S20 Paracordoma http://id.who.int/icd/release/11/mms XH2S71 Tumor pineal mixto http://id.who.int/icd/release/11/mms XH1S48 Tumor parenquimatoso pineal de diferenciación intermedia http://id.who.int/icd/release/11/mms XH1ZH1 Pineoblastoma http://id.who.int/icd/release/11/mms XH3D20 Tumor pineal de transición http://id.who.int/icd/release/11/mms XH7K24 Tumor neuroectodérmico, SAI http://id.who.int/icd/release/11/mms XH6P76 Tumor neuroectodérmico primitivo periférico http://id.who.int/icd/release/11/mms XH9GH0 Cordoma, SAI http://id.who.int/icd/release/11/mms XH8KJ8 Sarcoma de Ewing http://id.who.int/icd/release/11/mms XH0FH0 Tumor de Askin http://id.who.int/icd/release/11/mms XH17D8 Cordoma condroide http://id.who.int/icd/release/11/mms XH7303 Cordoma diferenciado http://id.who.int/icd/release/11/mms XH1AZ2 Craneofaringioma http://id.who.int/icd/release/11/mms XH15X9 Craneofaringioma, adamantinomatoso http://id.who.int/icd/release/11/mms XH2BF0 Craneofaringioma, papilar http://id.who.int/icd/release/11/mms XH8QA9 Pinealoma http://id.who.int/icd/release/11/mms XH1K94 Pineocitoma http://id.who.int/icd/release/11/mms XH1J36 Carcinoma mucoepidermoide http://id.who.int/icd/release/11/mms XH80V3 Tumor mucoepidermoide http://id.who.int/icd/release/11/mms XH7CL0 Angiomioma http://id.who.int/icd/release/11/mms XH9824 Leiomioma extraño http://id.who.int/icd/release/11/mms XH9662 Leiomioma celular http://id.who.int/icd/release/11/mms XH8S79 Leiomioma epitelioide http://id.who.int/icd/release/11/mms XH4729 Rabdomioma fetal http://id.who.int/icd/release/11/mms XH4FS5 Lipoleiomioma http://id.who.int/icd/release/11/mms XH1CZ1 Mioma http://id.who.int/icd/release/11/mms XH4EP9 Leiomioma plexiforme http://id.who.int/icd/release/11/mms XH4CY6 Leiomioma, SAI http://id.who.int/icd/release/11/mms XH9CC7 Leiomioma mixoide http://id.who.int/icd/release/11/mms XH8WG9 Rabdomioma, SAI http://id.who.int/icd/release/11/mms XH4BG5 Rabdomioma celular adulto http://id.who.int/icd/release/11/mms XH2736 Rabdomioma glicogénico http://id.who.int/icd/release/11/mms XH5AF2 Rabdomioma genital http://id.who.int/icd/release/11/mms XH8B88 Leiomioma apoplético http://id.who.int/icd/release/11/mms XH5Z76 Leiomioma hidrópico http://id.who.int/icd/release/11/mms XH5G84 Leiomioma cotiledonoide http://id.who.int/icd/release/11/mms XH6GV7 Miolipoma http://id.who.int/icd/release/11/mms XH27W3 Angiomiosarcoma http://id.who.int/icd/release/11/mms XH13Z5 Leiomisarcoma epitelioide http://id.who.int/icd/release/11/mms XH7ED4 Leiomiosarcoma, SAI http://id.who.int/icd/release/11/mms XH08B3 Rabdomiosarcoma embrionario mixto y rabdomiosarcoma alveolar http://id.who.int/icd/release/11/mms XH6YL0 Rabdomiosarcoma de tipo mixto http://id.who.int/icd/release/11/mms XH8H07 Miosarcoma http://id.who.int/icd/release/11/mms XH3122 Leiomiosarcoma mixoide http://id.who.int/icd/release/11/mms XH5SX9 Rabdomiosarcoma pleomórfico, SAI http://id.who.int/icd/release/11/mms XH4VB5 Rabdomiosarcoma pleomórfico, tipo adulto http://id.who.int/icd/release/11/mms XH0GA1 Rabdomiosarcoma, SAI http://id.who.int/icd/release/11/mms XH83G1 Rabdomiosarcoma embrionario, SAI http://id.who.int/icd/release/11/mms XH4749 Rabdomiosarcoma pleomórfico, pleomórfico http://id.who.int/icd/release/11/mms XH7V57 Sarcoma botrioides http://id.who.int/icd/release/11/mms XH7NM2 Rabdomiosarcoma de células fusiformes http://id.who.int/icd/release/11/mms XH7099 Rabdomiosarcoma alveolar http://id.who.int/icd/release/11/mms XH0S12 Ectomesenquimoma http://id.who.int/icd/release/11/mms XH60C2 Leiomiomatosis intravascular